ESZOPICLONE SECRETS

mavorixafor will increase the level or result of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Observe for adverse effects of sensitive CYP3A4 substrates if coadministered with mavorixafor (a weak CYP3A4 inhibitor).Stay away from concomitant usage of tucatinib with CYP3A substrates, where by negligib